Water, Sanitation and Hygiene Services
APAC
Updated
Reviewed by Chandani Patel
APAC Pharmacovigilance Services Market Industry Trends and Forecast to 2034: Segmented by (Service, Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$4.39 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.07 Bn | — | — |
| 2025 (base) | $2.33 Bn | +$258.8 Mn | — |
| 2026 (forecast) | $2.62 Bn | +$291.1 Mn | +12.5% |
| 2027 (forecast) | $2.95 Bn | +$327.5 Mn | +26.6% |
| 2028 (forecast) | $3.32 Bn | +$368.5 Mn | +42.4% |
| 2029 (forecast) | $3.73 Bn | +$414.5 Mn | +60.2% |
| 2030 (forecast) | $4.20 Bn | +$466.3 Mn | +80.2% |
| 2031 (forecast) | $4.72 Bn | +$524.6 Mn | +102.7% |
| 2032 (forecast) | $5.31 Bn | +$590.2 Mn | +128.1% |
| 2033 (forecast) | $5.98 Bn | +$664.0 Mn | +156.6% |
| 2034 (forecast) | $6.72 Bn | +$747.0 Mn | +188.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $2.33 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $6.72 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Service, model and end user (see all) |
| Key players | IQVIA, ArisGlobal, Parexel, Accenture, Cognizant (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Pharmacovigilance services collect and review reports of side effects to keep medicines safe after approval.
Key segments of the pharmacovigilance Services market include service (Case Processing, Signal Detection and Risk Management) and model (Outsourced and In-House Software).
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmacovigilance Services market. Many companies now outsource work they used to do in-house.
Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the pharmacovigilance Services market room to grow.
Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the pharmacovigilance Services market.
The pharmacovigilance Services market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
How care is paid for in some of these countries: Medicare and the PBS (Australia)[1], basic medical insurance (China)[2], the Hospital Authority (Hong Kong)[3], Ayushman Bharat PM-JAY (India)[4], public health insurance (Japan)[5], subsidised public care (Malaysia)[6], Pharmac (New Zealand)[7], PhilHealth (Philippines)[8], MediShield Life (Singapore)[9] and the Universal Coverage Scheme (Thailand)[10].
[1] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
[2] National Healthcare Security Administration. Checked 14 Nov 2026.
[3] Hospital Authority. Checked 14 Nov 2026.
[4] National Health Authority (PM-JAY). Checked 14 Nov 2026.
[5] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
[6] Ministry of Health Malaysia. Checked 14 Nov 2026.
[7] Pharmac. Checked 14 Nov 2026.
[8] PhilHealth. Checked 14 Nov 2026.
[9] CPF Board, MediShield Life. Checked 14 Nov 2026.
[10] National Health Security Office. Checked 14 Nov 2026.
Licensing, quality standards and payment models from public and private payers shape how pharmacovigilance Services services are delivered and paid for in APAC. Government health programs and insurance coverage are key to access.
What doctors and scientists are doing in Pharmacovigilance Services right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Digital Health · APAC
Pharmaceuticals · APAC
Digital Health · APAC
Digital Health · APAC
Pharmaceuticals · APAC
Pharmaceuticals · APAC